361 Capital LLC bought a new stake in Halyard Health, Inc. (NYSE:HYH) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 40,300 shares of the medical instruments supplier’s stock, valued at approximately $1,815,000. 361 Capital LLC owned 0.09% of Halyard Health at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of HYH. Riverhead Capital Management LLC grew its position in shares of Halyard Health by 88.1% in the second quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock valued at $126,000 after purchasing an additional 1,497 shares in the last quarter. LS Investment Advisors LLC grew its position in shares of Halyard Health by 16.1% in the second quarter. LS Investment Advisors LLC now owns 4,017 shares of the medical instruments supplier’s stock valued at $158,000 after purchasing an additional 556 shares in the last quarter. Victory Capital Management Inc. grew its position in shares of Halyard Health by 17.7% in the second quarter. Victory Capital Management Inc. now owns 4,732 shares of the medical instruments supplier’s stock valued at $186,000 after purchasing an additional 711 shares in the last quarter. Jarislowsky Fraser Ltd purchased a new position in Halyard Health during the third quarter worth about $200,000. Finally, QS Investors LLC grew its position in Halyard Health by 305.6% during the second quarter. QS Investors LLC now owns 5,176 shares of the medical instruments supplier’s stock worth $203,000 after buying an additional 3,900 shares in the last quarter. Hedge funds and other institutional investors own 90.31% of the company’s stock.
Halyard Health, Inc. (NYSE HYH) traded down $0.29 during mid-day trading on Monday, hitting $48.12. The company’s stock had a trading volume of 470,436 shares, compared to its average volume of 346,939. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19. The stock has a market cap of $2,320.00, a P/E ratio of 23.16, a price-to-earnings-growth ratio of 2.62 and a beta of 1.77. Halyard Health, Inc. has a 1 year low of $35.24 and a 1 year high of $50.99.
Halyard Health (NYSE:HYH) last posted its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.13. The company had revenue of $401.40 million for the quarter, compared to the consensus estimate of $394.54 million. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The firm’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.48 EPS. research analysts forecast that Halyard Health, Inc. will post 2.08 earnings per share for the current year.
Several equities analysts recently commented on the company. BidaskClub upgraded Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Zacks Investment Research lowered Halyard Health from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Stifel Nicolaus reaffirmed a “buy” rating and set a $45.00 price target on shares of Halyard Health in a research note on Thursday, September 21st. KeyCorp reissued a “hold” rating on shares of Halyard Health in a research note on Tuesday, October 17th. Finally, ValuEngine raised Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 4th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Halyard Health has an average rating of “Buy” and an average price target of $44.00.
TRADEMARK VIOLATION WARNING: This story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2017/12/04/361-capital-llc-invests-1-82-million-in-halyard-health-inc-hyh.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.